+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Novo Nordisk A/S - logo

Novo Nordisk is a global healthcare company with more than 90 years of innovation and leadership in diabetes care. Key products include diabetes care medications and devices. Novo Nordisk is also involved with hemostasis management, growth hormone therapy and hormone replacement therapy. Headquartered in Denmark, Novo Nordisk employs approximately 40,000 employees in 75 countries, and markets its products in more than 180 countries.

Insulin Syringes Market 2024-2028 - Product Thumbnail Image

Insulin Syringes Market 2024-2028

  • Report
  • July 2024
  • 139 Pages
  • Global
From
From
From
Insulin Detemir Injection Market - Global Forecast 2025-2030 - Product Thumbnail Image

Insulin Detemir Injection Market - Global Forecast 2025-2030

  • Report
  • August 2025
  • 187 Pages
  • Global
From
From
Lifestyle Drugs Market - Global Forecast 2026-2032 - Product Thumbnail Image

Lifestyle Drugs Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 182 Pages
  • Global
From
Obesity Treatment Market - Global Forecast 2026-2032 - Product Thumbnail Image

Obesity Treatment Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 185 Pages
  • Global
From
From
Anti-Obesity Therapeutics Market - Global Forecast 2026-2032 - Product Thumbnail Image

Anti-Obesity Therapeutics Market - Global Forecast 2026-2032

  • Report
  • January 2026
  • 193 Pages
  • Global
From
From
From
From
From
From
From
Diabetes Injection Pens - Global Strategic Business Report - Product Thumbnail Image

Diabetes Injection Pens - Global Strategic Business Report

  • Report
  • April 2026
  • 193 Pages
  • Global
From
From
Loading Indicator